EKTA.B

55.25

+0.18%↑

EKTA.B

55.25

+0.18%↑

EKTA.B

55.25

+0.18%↑

EKTA.B

55.25

+0.18%↑

EKTA.B

55.25

+0.18%↑

Search

Vivesto AB

Cerrado

0

Resumen

Variación precio

24h

Actual

Mínimo

Máximo

Métricas clave

By Trading Economics

Ingresos

-1.9M

-9.1M

BPA

-0.015

Empleados

4

EBITDA

-1.8M

-8.9M

Dividendos

By Dow Jones

Próximas Ganancias

7 may 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

36M

87M

Apertura anterior

0

Cierre anterior

0

Vivesto AB Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

12 abr 2026, 23:44 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Nikkei Likely to Fall After U.S.-Iran Peace Talks Break Down -- Market Talk

12 abr 2026, 23:38 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Oil Climbs as U.S.-Iran Peace Talks Fail, U.S. Navy Starts Blockade of Strait of Hormuz -- Market Talk

12 abr 2026, 23:38 UTC

Charlas de Mercado

Australia's Upstream Energy Companies Poised for Consensus Earnings Upgrades -- Market Talk

12 abr 2026, 23:36 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Gold Falls as Dollar Strengthens After U.S.-Iran Peace Talks Collapse -- Market Talk

12 abr 2026, 23:31 UTC

Charlas de Mercado

A2 Milk's Supply Issues Likely Temporary -- Market Talk

12 abr 2026, 23:09 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Australian Dollar Hammered by Blockade of Iran Ports -- Market Talk

12 abr 2026, 23:06 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

12 abr 2026, 23:06 UTC

Charlas de Mercado

Australian Dollar Ripe for a Downward Correction -- Market Talk

12 abr 2026, 22:56 UTC

Noticias de Eventos Importantes

Spot Gold Falls 1.9% to $4,658.65 per Ounce

12 abr 2026, 22:54 UTC

Noticias de Eventos Importantes

Front-Month Brent Crude Oil Futures Rise 7.6% to $102.42 per Barrel

12 abr 2026, 22:53 UTC

Noticias de Eventos Importantes

Front-Month WTI Crude Oil Futures Rise 8.3% to $104.56 per Barrel, ICE Data Show

12 abr 2026, 22:51 UTC

Noticias de Eventos Importantes

Front-Month Crude Oil Futures Climb After U.S.-Iran Peace Talks Break Down

12 abr 2026, 22:50 UTC

Charlas de Mercado
Noticias de Eventos Importantes

US Dollar Climbs Amid Broad Risk Off Mood In FX Market -- Market Talk

12 abr 2026, 22:37 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Australian Dollar Under Fire as Middle East Tensions Ratchet Up Again -- Market Talk

11 abr 2026, 08:20 UTC

Charlas de Mercado

Energy & Utilities Roundup: Market Talk

11 abr 2026, 08:20 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

11 abr 2026, 08:20 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Basic Materials Roundup: Market Talk

11 abr 2026, 00:00 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Big Yachts, Big Bucks -- Barrons.com

10 abr 2026, 21:55 UTC

Adquisiciones, fusiones, absorciones

Paramount Warrants Are an Underappreciated Aspect of Warner Bros. Deal -- Barrons.com

10 abr 2026, 21:01 UTC

Ganancias

Cango Inc.: Files Annual Report on Form 20-F With SEC

10 abr 2026, 20:50 UTC

Charlas de Mercado

Energy & Utilities Roundup: Market Talk

10 abr 2026, 20:50 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Basic Materials Roundup: Market Talk

10 abr 2026, 20:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

10 abr 2026, 20:31 UTC

Charlas de Mercado

Convenience Store Traffic Slows as Gas Prices Rise -- Market Talk

10 abr 2026, 20:10 UTC

Adquisiciones, fusiones, absorciones

This Women's Health Company Is Drawing Takeover Interest. The Stock Is Soaring. -- Barrons.com

10 abr 2026, 19:15 UTC

Charlas de Mercado

Global Energy Roundup: Market Talk

10 abr 2026, 19:15 UTC

Charlas de Mercado

Oil Futures Settle Lower With Focus on U.S.-Iran Talks -- Market Talk

10 abr 2026, 19:08 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

10 abr 2026, 19:08 UTC

Charlas de Mercado

U.S. Natural Gas Futures End Week Lower -- Market Talk

10 abr 2026, 18:38 UTC

Charlas de Mercado

Canada's Job Market Showing Soft Demand, Structural Decline in Supply -- Market Talk

Comparación entre iguales

Cambio de precio

Vivesto AB previsión

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Vivesto AB

Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.
help-icon Live chat